Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Newport Pharmaceuticals International |
---|---|
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00002297 |
The objectives of this study are to determine the effects of isoprinosine in patients diagnosed as having unexplained generalized lymphadenopathy. Variables to be examined will include:
Signs and symptoms:
Cell-mediated immune system parameters:
Safety parameters:
Condition | Intervention |
---|---|
Lymphatic Disease HIV Infections |
Drug: Inosine pranobex |
Study Type: | Interventional |
Study Design: | Treatment, Double-Blind |
Official Title: | A Multi-Center Double-Blind Placebo-Controlled Study to Investigate the Action of Isoprinosine (Inosiplex) in Patients With Unexplained Generalized Lymphadenopathy |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Exclusion Criteria
Co-existing Condition:
Patients with a history of gout, uric acid urolithiasis, uric acid nephrolithiasis, renal dysfunction, or gastric ulceration are excluded.
Concurrent Medication:
Excluded:
Critically ill patients or those with CDC-defined AIDS are excluded.
Prior Medication:
Excluded within 1 month of study entry:
Patients with persistent generalized lymphadenopathy (PGL).
Study ID Numbers: | 008A, ISO-103-USA |
Study First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00002297 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Inosine Pranobex AIDS-Related Complex |
Sexually Transmitted Diseases, Viral Immunologic Factors Acquired Immunodeficiency Syndrome Adjuvants, Immunologic AIDS-Related Complex Inosine Pranobex Antiviral Agents |
Immunologic Deficiency Syndromes Virus Diseases Lymphatic Diseases HIV Infections Sexually Transmitted Diseases Retroviridae Infections |
Anti-Infective Agents RNA Virus Infections Sexually Transmitted Diseases, Viral Slow Virus Diseases Immunologic Factors Immune System Diseases Physiological Effects of Drugs Acquired Immunodeficiency Syndrome Adjuvants, Immunologic Inosine Pranobex Infection |
Antiviral Agents Pharmacologic Actions Immunologic Deficiency Syndromes Virus Diseases Lymphatic Diseases HIV Infections Therapeutic Uses Sexually Transmitted Diseases Lentivirus Infections Retroviridae Infections |